Avanir Targets Wockhardt In Nuedexta Patent Blitz
Avanir Pharmaceuticals Inc. on Tuesday sued drugmaker Wockhardt Ltd. in an effort to block its plans to make a generic version of mental health drug Nuedexta, marking the latest complaint in...To view the full article, register now.
Already a subscriber? Click here to view full article